home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Third Tine Of Anthrax's Toxic Trident

  January, 28 2002 3:43
your information resource in human molecular genetics
Three poisonous proteins make the anthrax bacteria, Bacillus anthracis, deadly. One shields the other two from the body's immune system, and another destroys immune-system cells. The third anthrax toxin, called oedema factor (EF), causes fluid accumulation, which can be deadly in its own right.

Following its recent publication of the structure of the first two toxins, this week's Nature (Vol. 415, No. 6870, 24 January 2002) contains a description of the structure of anthrax EF from Andrew Bohm at the Boston Medical Resarch Institute, Massachusetts, Wei-Jen Tang at the University of Chicago, Illinois, and colleagues.

The third tine of anthrax's toxic trident is harmless until it meets a crucial signalling molecule called calmodulin. The EF–calmodulin complex has a striking enzymatic activity, generating the important cellular signalling molecule cyclic AMP (cAMP). Normally, this is made by a designated cellular enzyme. EF has evolved to do the same job, only far more efficiently and through an entirely different mechanism. cAMP generation is thought to be important for the lethal effect of EF, so this difference provides hope that specific reagents can be developed to target EF and not essential cellular signalling pathways.

EF could also be a weak link, as its structure contains a deep, well defined molecular pocket that could represent an ideal target for future drugs. Bohm, Tang and colleagues "complete our atomic-resolution view of this toxic trinity", says Robert Liddington of the Burnham Institute in La Jolla, California, in an accompanying News and Views article.


Andrew Bohm
tel +1 617 658 7767
e-mail bohm@bbri.org

Wei-Jen Tang
tel +1 773 702 4331
e-mail wtang@midway.uchicago.edu

Robert Liddington
tel +1 858 646 3136
e-mail rlidding@burnham-inst.org

(C) Naturepress release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.